Science Current Events | Science News | Brightsurf.com
 
Email a Friend Send to a friend
Printer Friendly Print Despite vaccine, public should not get complacent about pneumococcal disease

Despite vaccine, public should not get complacent about pneumococcal disease

June 03, 2008

Although the childhood pneumococcal conjugate vaccine has been a boon in reducing the incidence invasive pneumococcal disease (IPD), the public and the medical community must not get complacent, as non-vaccine strains, some resistant to antibiotics, are on the rise, say scientists at a meeting today in Boston.

"We have a vaccine that has dramatically reduced the total burden of pneumococcal disease. It targets 7 strains of the bacteria that were responsible for 90 percent of cases of severe pnuemococcal infection. While that is good news, we still need to be concerned about the replacement strains that are rising to take their place," says Keith Klugman of Emory University, speaking to the 108th General Meeting of the American Society for Microbiology.




Streptococcus pneumoniae, also called pneumococcus, is one of the most common causes of bacterial pneumonia and deadly bloodstream infections in the United States. It can also cause bacterial meningitis in children and adults. In its less severe forms it commonly causes ear infections. Pneumococcus bacteria can be found colonizing many people's noses without causing infection. Why it suddenly invades the body and causes disease is unknown.

A vaccine against pneumococcal disease has been available for adults and children over 2 years of age since the 1980s, but in 2000 a new vaccine, known as PCV7, was approved by the FDA for children under 5 years of age.

Since the introduction of PCV7, the Centers for Disease Control and Prevention (CDC) has reported a significant decline in IPD rates among all age levels, but the incidence of IPD caused by strains not included in the vaccine rose by 40%. The most prevalent non-vaccine strain is 19A.

"The PCV7 vaccine contained strain 19F, which is similar to 19A. It was hoped that this would provide some level of protection against 19A. This does not appear to have been the case," says Klugman.

Of additional concern is the fact that 19A infections are showing up that are resistant to multiple antibiotics. Klugman warns that unncessary antibiotic use driving the development of resistant bacteria and that physicians should prescribe antibiotics only when necessary.

The good news is there is a new vaccine on the horizon, and it contains 13 instead of 7 of the most common pneuococcal strains, including 19A. It is currently in late phase III clinical trials and is most likely to replace PCV7 once it is approved, which could be in the next year or two.

"If we didn't have PCV13 around the corner, I think our sense of unease would be much greater," says Klugman.

American Society for Microbiology



Related Pneumococcal Current Events and Pneumococcal News Articles Pneumococcal Current Events and Pneumococcal News RSS Pneumococcal Current Events and Pneumococcal News RSS
Inappropriate sepsis therapy leads to fivefold reduction in survival
Patients experiencing septic shock who receive inappropriate therapy may have a fivefold reduction in survival, shows a new study.

Scientists create NICE solution to pneumonia vaccine testing problems
Medical clinics the world over could benefit from new software* created at the National Institute of Standards and Technology (NIST), where a team of scientists has found a way to improve the efficiency of a pneumonia vaccine testing method developed at the University of Alabama at Birmingham (UAB).

Review: Pneumococcal conjugate vaccines effective at preventing child deaths
A study published in The Cochrane Review this month concludes that pneumococcal conjugate vaccines (PCV), already known to prevent invasive pneumococcal disease (IPD) and x-ray defined pneumonia, was also effective against child deaths.

New WHO data underscores global threat of the world's leading child killer
New World Health Organization data to be published in this week's edition of the Lancet will shed new light on two leading causes of pneumonia, the world's leading killer of children under age 5, both globally and within specific countries.

New vaccine shows promise for COPD patients at risk for pneumonia
A new vaccine against pneumonia may offer better protection from chronic obstructive pulmonary disease (COPD) patients than the currently accepted vaccine, according to recent research that will be published in the September 15 issue of the American Journal of the Respiratory and Critical Care Journal, a publication of the American Thoracic Society.

How meningitis bacteria attack the brain
A specific protein on the surface of a common bacterial pathogen allows the bacteria to leave the bloodstream and enter the brain, initiating the deadly infection known as meningitis.

NIAID set to launch clinical trials to test 2009 H1N1 influenza vaccine candidates
Scientists in a network of medical research institutions across the United States are set to begin a series of clinical trials to gather critical data about influenza vaccines, including two candidate H1N1 flu vaccines.

Statins don't lower risk of pneumonia in elderly
Taking popular cholesterol-lowering statin drugs, such as Lipitor® (atorvastatin), does not lower the risk of pneumonia.

From poison to prevention
One of the major challenges in modern vaccinology is to engineer vectors that are highly infectious, yet don't cause illness. Trickier still is to ensure that such weapons against infectious disease can be safely disarmed, once their immunogenic work is done.

Pneumococcal vaccine does not appear to protect against pneumonia
Commonly used pneumococcal polysaccharide vaccines do not appear to be effective for preventing pneumonia.
More Pneumococcal Current Events and Pneumococcal News Articles
  The Clinical Impact of Pneumococcal Disease And Strategies for Its Prevention (International Congress & Symposium)
by Richard T. Mayon-White (Author)



Pneumococcal Vaccines: The Impact of Conjugate Vaccine

Pneumococcal Vaccines: The Impact of Conjugate Vaccine
by George R. Siber (Editor), Keith P. Klugman (Editor), P. Helena Makela (Editor)

This book explains how to monitor and measure the effects of pneumococcal conjugate vaccine introduction. It summarizes the most current information on pneumococcal conjugate vaccines. The book: discusses the world-wide potential of the vaccines; details the impact of vaccination on childhood respiratory disease, including antibiotic resistance; makes clear the biology of the pneumococcus in relation to disease; and, explains the dynamics of a successful vaccine launch.

  Most FPs Strongly Recommend Pneumococcal Vaccine.(Brief Article): An article from: Family Practice News
by Elizabeth Mechcatie (Author)

This digital document is an article from Family Practice News, published by International Medical News Group on October 1, 2001. The length of the article is 666 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Most FPs Strongly Recommend Pneumococcal Vaccine.(Brief Article)
Author: Elizabeth Mechcatie
Publication: Family Practice News (Magazine/Journal)
Date: October 1, 2001
Publisher: International Medical News Group
Volume: 31 Issue: 19 Page: 21

Article Type: Brief Article

Distributed by Thomson...

  Pneumococcal susceptibility to meropenem in a Mid-South children's hospital.: An article from: Southern Medical Journal
by Steven C. Buckingham (Author), Yvonne Davis (Author), B. Keith English (Author)

This digital document is an article from Southern Medical Journal, published by Southern Medical Association on November 1, 2002. The length of the article is 2413 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Pneumococcal susceptibility to meropenem in a Mid-South children's hospital.
Author: Steven C. Buckingham
Publication: Southern Medical Journal (Refereed)
Date: November 1, 2002
Publisher: Southern Medical Association
Volume: 95 Issue: 11 Page: 1293(4)

Distributed by Thomson...

  Many adult diabetics not getting vaccines: pneumococcal, flu. (Infectious Diseases).: An article from: Internal Medicine News
by Sharon Worcester (Author)

This digital document is an article from Internal Medicine News, published by International Medical News Group on July 1, 2003. The length of the article is 451 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Many adult diabetics not getting vaccines: pneumococcal, flu. (Infectious Diseases).
Author: Sharon Worcester
Publication: Internal Medicine News (Magazine/Journal)
Date: July 1, 2003
Publisher: International Medical News Group
Volume: 36 Issue: 13 Page: 32(1)

Distributed by Thomson...

  Pneumococcal Vaccine Shift Eyed.: An article from: Family Practice News
by Miriam E. Tucker (Author)

This digital document is an article from Family Practice News, published by International Medical News Group on April 15, 2000. The length of the article is 807 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Pneumococcal Vaccine Shift Eyed.
Author: Miriam E. Tucker
Publication: Family Practice News (Magazine/Journal)
Date: April 15, 2000
Publisher: International Medical News Group
Volume: 30 Issue: 8 Page: 1

Distributed by Thomson...

  Pneumococcal vaccine may limit resistance. (Antibiotics and S. Pneumoniae).: An article from: Internal Medicine News
by Damian McNamara (Author)

This digital document is an article from Internal Medicine News, published by International Medical News Group on May 15, 2002. The length of the article is 532 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Pneumococcal vaccine may limit resistance. (Antibiotics and S. Pneumoniae).
Author: Damian McNamara
Publication: Internal Medicine News (Magazine/Journal)
Date: May 15, 2002
Publisher: International Medical News Group
Volume: 35 Issue: 10 Page: 14(1)

Distributed by Thomson...

  ACIP Scales Back Pneumococcal Vaccine Guideline.(Brief Article)(Statistical Data Included): An article from: Family Practice News
by Miriam E. Tucker (Author)

This digital document is an article from Family Practice News, published by International Medical News Group on March 15, 2000. The length of the article is 1029 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: ACIP Scales Back Pneumococcal Vaccine Guideline.(Brief Article)(Statistical Data Included)
Author: Miriam E. Tucker
Publication: Family Practice News (Magazine/Journal)
Date: March 15, 2000
Publisher: International Medical News Group
Volume: 30 Issue: 6 Page: 1

Article Type: Brief Article, Statistical Data Included

Distributed by Thomson...

  PCV Added to 2001 Immunization Schedule.(pneumococcal vaccine Prevnar): An article from: Family Practice News
by International Medical News Group (Publisher)

This digital document is an article from Family Practice News, published by International Medical News Group on January 1, 2001. The length of the article is 1216 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: PCV Added to 2001 Immunization Schedule.(pneumococcal vaccine Prevnar)
Publication: Family Practice News (Magazine/Journal)
Date: January 1, 2001
Publisher: International Medical News Group
Volume: 31 Issue: 1 Page: 24

Article Type: Calendar

Distributed by Thomson...

  Telephone intervention boosts pneumococcal vaccination rates.: An article from: Internal Medicine News
by Patrice Wendling (Author)

This digital document is an article from Internal Medicine News, published by Thomson Gale on July 15, 2006. The length of the article is 483 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Telephone intervention boosts pneumococcal vaccination rates.
Author: Patrice Wendling
Publication: Internal Medicine News (Magazine/Journal)
Date: July 15, 2006
Publisher: Thomson Gale
Volume: 39 Issue: 14 Page: 48(1)

Distributed by Thomson...

© 2009 BrightSurf.com